chr1-181483772-G-T
Position:
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 1P and 12B. PP2BP4_ModerateBP6_ModerateBS1BS2
The NM_001205293.3(CACNA1E):c.28G>T(p.Ala10Ser) variant causes a missense change. The variant allele was found at a frequency of 0.0000124 in 1,609,462 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.000072 ( 0 hom., cov: 31)
Exomes 𝑓: 0.0000062 ( 0 hom. )
Consequence
CACNA1E
NM_001205293.3 missense
NM_001205293.3 missense
Scores
3
16
Clinical Significance
Conservation
PhyloP100: 4.69
Genes affected
CACNA1E (HGNC:1392): (calcium voltage-gated channel subunit alpha1 E) Voltage-dependent calcium channels are multisubunit complexes consisting of alpha-1, alpha-2, beta, and delta subunits in a 1:1:1:1 ratio. These channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. This gene encodes the alpha-1E subunit of the R-type calcium channels, which belong to the 'high-voltage activated' group that maybe involved in the modulation of firing patterns of neurons important for information processing. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Apr 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -11 ACMG points.
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), CACNA1E. . Gene score misZ 5.8125 (greater than the threshold 3.09). Trascript score misZ 6.7013 (greater than threshold 3.09). GenCC has associacion of gene with developmental and epileptic encephalopathy, developmental and epileptic encephalopathy, 69.
BP4
Computational evidence support a benign effect (MetaRNN=0.1827536).
BP6
Variant 1-181483772-G-T is Benign according to our data. Variant chr1-181483772-G-T is described in ClinVar as [Benign]. Clinvar id is 1606362.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0000725 (11/151756) while in subpopulation AFR AF= 0.000266 (11/41314). AF 95% confidence interval is 0.000149. There are 0 homozygotes in gnomad4. There are 5 alleles in male gnomad4 subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High AC in GnomAd4 at 11 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CACNA1E | NM_001205293.3 | c.28G>T | p.Ala10Ser | missense_variant | 1/48 | ENST00000367573.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CACNA1E | ENST00000367573.7 | c.28G>T | p.Ala10Ser | missense_variant | 1/48 | 1 | NM_001205293.3 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0000725 AC: 11AN: 151756Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
11
AN:
151756
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000162 AC: 4AN: 247112Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 134220
GnomAD3 exomes
AF:
AC:
4
AN:
247112
Hom.:
AF XY:
AC XY:
0
AN XY:
134220
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000617 AC: 9AN: 1457706Hom.: 0 Cov.: 31 AF XY: 0.00000552 AC XY: 4AN XY: 725038
GnomAD4 exome
AF:
AC:
9
AN:
1457706
Hom.:
Cov.:
31
AF XY:
AC XY:
4
AN XY:
725038
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000725 AC: 11AN: 151756Hom.: 0 Cov.: 31 AF XY: 0.0000675 AC XY: 5AN XY: 74086
GnomAD4 genome
AF:
AC:
11
AN:
151756
Hom.:
Cov.:
31
AF XY:
AC XY:
5
AN XY:
74086
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
2
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Invitae | Jan 03, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Benign
DEOGEN2
Benign
.;.;.;.;T;T;.;T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;.;.;T;.;T;T;T;T
M_CAP
Benign
D
MetaRNN
Benign
T;T;T;T;T;T;T;T;T
MetaSVM
Uncertain
D
MutationAssessor
Benign
.;L;L;.;L;.;L;L;L
MutationTaster
Benign
D;D;D;N;N;N;N
PrimateAI
Uncertain
T
PROVEAN
Benign
.;N;.;N;N;.;.;.;.
REVEL
Benign
Sift
Benign
.;T;.;T;T;.;.;.;.
Sift4G
Benign
.;T;T;T;T;T;T;T;T
Polyphen
0.073
.;B;.;.;.;.;B;.;.
Vest4
0.080, 0.077, 0.13, 0.15, 0.14, 0.12, 0.14, 0.17
MVP
MPC
0.97
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at